July 02, 2019
"Revolving door influence-peddling smacks of corruption, and makes the American people rightly cynical and distrustful about whether high-level Trump administration officials are working for them, or for their future corporate employers." Senator Warren's Anti-Corruption and Public Integrity Act would prohibit companies like Pfizer from hiring senior government officials for at least four years after leaving government service. Gottlieb joined Pfizer's board just weeks after leaving government s
Senator Warren Calls on Former FDA Commissioner Scott Gottlieb to Resign from Pharmaceutical Giant Pfizer's Board of Directors
"Revolving door influence-peddling smacks of corruption, and makes the American people rightly cynical and distrustful about whether high-level Trump administration officials are working for them, or for their future corporate employers." Senator Warren's Anti-Corruption and Public Integrity Act would prohibit companies like Pfizer from hiring senior government officials for at least four years after leaving government service. Gottlieb joined Pfizer's board just weeks after leaving government s
Washington, DC - United States Senator Elizabeth
Warren (D-Mass.) sent a letter to Scott Gottlieb, the former Commissioner of
the U.S. Food and Drug Administration (FDA) who recently joined the
board of directors at Pfizer, calling on Dr. Gottlieb to resign from his
position at Pfizer. Senator Warren noted that Pfizer has billions of dollars at
stake in FDA decisions and wrote that his board appointment is exactly the kind
of "revolving door influence-peddling" that causes Americans to lose
faith in government. "This will certainly be a lucrative move for you -- according to
Pfizer, board members in 2018 were paid $142,500 in cash retainers, plus
received $192,500 worth of Pfizer stock," wrote Senator
Warren in her letter to Dr. Gottlieb. "But this kind of
revolving door influence-peddling smacks of corruption, and makes the American
people rightly cynical and distrustful about whether high-level Trump
administration officials are working for them, or for their future corporate
employers." Dr. Gottlieb is the second high-level Trump Administration official in
less than two months who, soon after leaving government service,
joined the board of a corporation with interests related to their work in
the administration. Former Department of Homeland Security Secretary
and Chief of Staff John Kelly helped lead the Trump administration's "zero-tolerance"
immigration policy that led to forcibly separating thousands of migrant
children from their parents. Shortly after leaving government, General Kelly joined the board of Caliburn, Inc., the parent company of the
Comprehensive Health Services, which runs the Homestead Temporary Shelter
for Unaccompanied Children in Florida. Senator Warren and her colleague
Congresswoman Pramila Jayapal (D-Wash.) opened an investigation into
General Kelly's associations with Caliburn before, during, and after his time
in government. Senator Warren's sweeping ethics legislation, the Anti-Corruption
and Public Integrity Act, would shut the revolving door and prohibit giant
companies like Pfizer from wielding undue influence by hiring or compensating
any senior government officials for at least four years after leaving
government service, among other measures to root out corruption in government.
Representatives Jayapal and John Sarbanes (D-Md.) introduced the companion bill
in the U.S. House of Representatives. From former
oil lobbyists running federal agencies to those responsible for
protecting our environment and
interior, the bill would crack down on all
forms of corruption and peddling. "I intend to keep working to make that plan law," wrote
Senator Warren to Dr. Gottlieb. "In the interim, however,
you should rectify your mistake and immediately resign from your position as a
Pfizer board member. Doing so would send a strong and necessary message to the
American people about the importance of government ethics and the integrity of
current and former federal officials." Senator Warren has previously criticized
Pfizer for reneging on a promise not to hike up the prices on many of
its prescription drugs as Americans struggle to afford the medications they
need.
###
Next Article Previous Article